OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

RCUS — Arcus Biosciences, Inc.

NYSE

FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 5, 2026

REVENUE

$17.0M -48.5%

NET MARGIN

-752.9% -456.0 PTS

EPS

-$1.02 -10.9%

FREE CASH FLOW

-$138.0M -14.0%

No summary has been written for this call yet.